Infineon Technologies AG (IFX)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 49.89 |
|---|---|
| 52-week range | 31.27 – 88.83 |
| Return, 1 month / 3 months | −17.0% / −28.5% |
| Return, 1 year / 3 years | +46.9% / +74.4% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 53.7% |
| Worst drawdown (1 year) | -43.3% |
| Average daily value traded | 227.73M EUR |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Infineon Technologies is a semiconductor company based near Munich in Germany. It designs and manufactures power semiconductors, microcontrollers, sensors and security chips. Its customers are mainly automotive, industrial and consumer electronics manufacturers, along with firms working in energy, data centres and payment security. Infineon supplies components used in electric vehicles, renewable energy systems, industrial automation and smart cards, and it also offers software and services that support its chips.
The shares are listed on the XETRA Stock Exchange in Germany under the code IFX, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Infineon Technologies AG (IFX) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 49.89 on 22 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 438 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 46.9% and over the last three months it fell 28.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.2% | ||
| From 52-week high | -43.3% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -28.5% | ||
| 6-month return | 1.0% | ||
| 12-month return, skipping the last month | 77.1% | ||
| Stability (higher is calmer) | 24 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.3% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 227.73M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 31 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.9% |
|---|---|
| 1 month | −17.0% |
| 3 months | −28.5% |
| 6 months | +1.0% |
| 1 year | +46.9% |
| 3 years | +74.4% |
| 5 years | +35.1% |
Signals
| 50-day / 200-day average | 56.94 / 56.80 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.75 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Feb 2026 | EUR 0.3500 |
| 21 Feb 2025 | EUR 0.3500 |
| 26 Feb 2024 | EUR 0.3500 |
| 17 Feb 2023 | EUR 0.3200 |
| 18 Feb 2022 | EUR 0.2700 |
| 26 Feb 2021 | EUR 0.2200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.